Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ARG2 | P78540 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | TOP1 | P11387 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL861788 | 0.82 | MAOB (0.55) | MAOBCA1CA2ARG2CALM1 | |
| SCHEMBL4596064 | 0.76 | GPR52 (0.44) | MAOBCA1CA2LOXL2 | |
| SCHEMBL5699094 | 0.76 | TRPA1 (0.42) | MAOBIDO1LOXL2 | |
| SCHEMBL7360946 | 0.76 | CYP1A2 (0.44) | CYP1A2LOXL2 | |
| SCHEMBL7569322 | 0.76 | IDO1 (0.41) | CA1CA2CYP1A2IDO1TP53 | |
| Allylbenzene SCHEMBL693022 | 0.76 | MAOB (0.48) | MAOBCA1CA2ARG2CALM1 | |
| SCHEMBL1387883 | 0.76 | ESR1 (0.44) | CA2IDO1 | |
| SCHEMBL460253 | 0.75 | MAOB (0.52) | MAOBCA1CA2ARG2CALM1 | |
| SCHEMBL15282878 | 0.75 | MAOB (0.52) | MAOBCA1CA2ARG2CALM1 | |
| SCHEMBL11349290 | 0.75 | MAOB (0.52) | MAOBCA1CA2ARG2CALM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1042 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117886839-A | Organic semiconductor luminescent compound and application thereof | 冠能光电材料(深圳)有限责任公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117599843-A | Bimetallic molecular sieve and preparation method and application thereof | 连云港高晶吕新材料有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116042316-A | Essential oil for improving respiratory tract comfort and bead-explosion essential oil for cigarettes | 四川三联新材料有限公司 | 2023-05-02 | — | — | CN | claimed |
| EP-4121220-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2023-01-25 | — | — | EP | claimed |
| CN-115433203-A | Amine fluorinated curcumenol derivative compound and application and preparation method thereof | 华东理工大学 | 2022-12-06 | — | — | CN | claimed |
| CN-114773237-A | Novel phenylpropenyl hydroximic acid derivatives containing sulfonate structure, and preparation method and application thereof | 南京大学 | 2022-07-22 | — | — | CN | claimed |
| WO-2021185933-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | MOLECULAR PLASMA GROUP S.A. (LU) | 2021-09-23 | — | — | WO | claimed |
| EP-3881942-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2021-09-22 | — | — | EP | claimed |
| CN-113387831-A | Amide compound and application thereof in preparation of neuroinflammation inhibitor | 苏州大学 | 2021-09-14 | — | — | CN | claimed |
| CN-112695549-A | Low-temperature soaping agent for printing of reactive dye and preparation method thereof | 浙江震东新材料有限公司 | 2021-04-23 | — | — | CN | claimed |
| US-5716928-A | ADMINISTERING DRUG CONCURRENTLY WITH ESSENTIAL OIL | AVMAX, INC. (US) | 1998-02-10 | — | — | US | claimed |
| US-5665386-A | Use of essential oils to increase bioavailability of oral pharmaceutical compounds | AVMAX, INC. (US) | 1997-09-09 | — | — | US | claimed |
| WO-1996040192-A1 | USE OF ESSENTIAL OILS TO INCREASE BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOUNDS | AVMAX, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| JP-H08509967-A | — | — | 1996-10-22 | — | — | JP | claimed |
| EP-0691959-A1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1996-01-17 | — | — | EP | claimed |
| EP-0690847-A1 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1996-01-10 | — | — | EP | claimed |
| WO-1994022835-A2 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | claimed |
| WO-1994022834-A1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | claimed |
| EP-0564648-A1 | NOVEL ACONITINE COMPOUND AND ANALGESIC/ANTIINFLAMMATORY AGENT | SANWA SHOYAKU KABUSHIKI KAISHA (JP) | 1993-10-13 | — | — | EP | claimed |
| US-4981847-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-01-01 | — | — | US | claimed |